Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:

E-Prescribing Coalition Offers Free, Web-Based System To Physicians

  • News

Executive Summary

A coalition of technology and insurance companies led by clinical software company Allscripts aims to spur growth in electronic prescribing, even among small physician practices, by offering a free, user-friendly, Web-based system

You may also be interested in...



BCBS Of North Carolina Offers E-Prescribing Incentive To Providers

While Medicare will start providing financial incentives to physicians to use e-prescribing starting in 2009, some private plans are already paying physicians and pharmacies to adopt the technology

BCBS Of North Carolina Offers E-Prescribing Incentive To Providers

While Medicare will start providing financial incentives to physicians to use e-prescribing starting in 2009, some private plans are already paying physicians and pharmacies to adopt the technology

E-Prescribing’s Hurdle May Be DEA, Not Technology Or Physicians

The Drug Enforcement Administration has pledged to issue rules permitting electronic prescribing of controlled substances, but neither the rules nor even a firm publication date appear forthcoming

Table

View full table

Related Content

Pink Sheet
Tags:
UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By